DHR Danaher Corporation Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR'da Görüntüle ↗ kapat Eki 5, 2026 10-K/10-Q Tem 21, 2026DHR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
DHR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 02 Ekim 2023 | 141-for-125 | İleri |
| 05 Temmuz 2016 | 1319-for-1000 | İleri |
| 14 Haziran 2010 | 2-for-1 | İleri |
| 21 Mayıs 2004 | 2-for-1 | İleri |
| 01 Haziran 1998 | 2-for-1 | İleri |
| 23 Ocak 1995 | 2-for-1 | İleri |
| 09 Eylül 1987 | 2-for-1 | İleri |
Danaher Corporation Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law. The name came from a river in Montana.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | DHR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 39.25Y ort. ≈36.6 | ≈36.6 | 32.0 | Aşırı değerli | |
| F/S (TTM) | 6.25Y ort. ≈7.1 | ≈7.1 | 5.4 | Adil değer | |
| F/D (MRQ) | 3.05Y ort. ≈3.5 | ≈3.5 | 6.9 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 28.45Y ort. ≈28.9 | ≈28.9 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 23.45Y ort. ≈23.8 | ≈23.8 | 25.7 | Adil değer | |
| Fiyat / Maddi Defter Değeri (MRQ) | 5.0 | · | · | · | |
| PEG Ratio (PEG Oranı) | ≈60.3 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | DHR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 58.5%5Y ort. ≈59.7% | ≈59.7% | 57.6% | Aynı seviyede | |
| Faaliyet Kâr Marjı (TTM) | 20.4%5Y ort. ≈22.8% | ≈22.8% | 18.0% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | 19.1%5Y ort. ≈27.5% | ≈27.5% | 18.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 19.0%5Y ort. ≈22.0% | ≈22.0% | 18.9% | Aynı seviyede | |
| Net Kâr Marjı (TTM) | 15.9%5Y ort. ≈19.1% | ≈19.1% | 15.8% | Zayıf | |
| ROA (TTM) | 4.6%5Y ort. ≈6.3% | ≈6.3% | 11.5% | Zayıf | |
| ROE (TTM) | 7.6%5Y ort. ≈10.8% | ≈10.8% | 18.4% | Zayıf | |
| ROIC | 5.6%5Y ort. ≈7.7% | ≈7.7% | 13.8% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | DHR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.55Y ort. ≈0.4 | ≈0.4 | 0.4 | Yüksek borç | |
| Cari Oran (MRQ) | 1.75Y ort. ≈1.7 | ≈1.7 | 1.7 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 0.65Y ort. ≈0.5 | ≈0.5 | 0.8 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.55Y ort. ≈0.4 | ≈0.4 | 0.4 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | DHR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 2.9%5Y ort. ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -2.7%5Y ort. ≈-0.53% | ≈-0.53% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 2.0% | · | · | · | |
| EPS YoY (EPS YB) | -4.5%5Y ort. ≈6.5% | ≈6.5% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -7.3%5Y ort. ≈5.8% | ≈5.8% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -19.4%5Y ort. ≈-8.4% | ≈-8.4% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 0.65% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -20.6%5Y ort. ≈-8.9% | ≈-8.9% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -0.18% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | DHR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.3 | ≈0.3 | 0.6 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 4.25Y ort. ≈4.1 | ≈4.1 | 3.3 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 6.65Y ort. ≈6.5 | ≈6.5 | 5.3 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$423.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Eyl 30, 2026 | $0,40 | USD | ≈0.69% |
| Haz 26, 2026 | $0,40 | USD | ≈0.73% |
| Mar 27, 2026 | $0,40 | USD | ≈0.75% |
| Ara 26, 2025 | $0,32 | USD | ≈0.56% |
| Eyl 26, 2025 | $0,32 | USD | ≈0.67% |
| Haz 27, 2025 | $0,32 | USD | ≈0.59% |
| Mar 28, 2025 | $0,32 | USD | ≈0.55% |
| Ara 27, 2024 | $0,27 | USD | ≈0.47% |
| Eyl 27, 2024 | $0,27 | USD | ≈0.38% |
| Haz 28, 2024 | $0,27 | USD | ≈0.42% |
| Mar 27, 2024 | $0,27 | USD | ≈0.41% |
| Ara 28, 2023 | $0,24 | USD | ≈0.42% |
| Eki 11, 2023 | $0,27 | USD | ≈0.45% |
| Haz 29, 2023 | $0,24 | USD | ≈0.44% |
| Mar 30, 2023 | $0,24 | USD | ≈0.41% |
| Ara 29, 2022 | $0,22 | USD | ≈0.37% |
| Eyl 29, 2022 | $0,22 | USD | ≈0.37% |
| Haz 23, 2022 | $0,22 | USD | ≈0.36% |
| Mar 24, 2022 | $0,22 | USD | ≈0.31% |
| Ara 29, 2021 | $0,19 | USD | ≈0.26% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 20, 2026 | $1.94 | $1.85 | 4.7% |
| 31 Mart 2026 | $2.06 | $1.96 | 5.3% | |
| 31 Aralık 2025 | $2.23 | $2.17 | 2.6% | |
| 30 Eylül 2025 | $1.89 | $1.74 | 8.7% | |
| 30 Haziran 2025 | $1.80 | $1.66 | 8.4% | |
| 31 Mart 2025 | $1.88 | $1.66 | 13.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.32 | $68.90 | $72.36 | $68.77 | $63.17 | $55.93 | $43.52 | $40.22 | $37.84 | $33.23 | $34.49 | $33.19 | |
| Revenue / Share | $34.31 | $32.39 | $32.15 | $42.70 | $39.97 | $31.01 | $24.69 | $28.01 | $25.96 | $24.12 | $29.02 | $27.81 | |
| Cash Flow / Share | $8.96 | $9.07 | $9.64 | $11.56 | $11.34 | $8.64 | $5.45 | $5.66 | $4.93 | $5.03 | $5.37 | $5.25 | |
| Cash / Share | · | · | · | · | · | · | $28.63 | $1.12 | $0.90 | $1.39 | $1.15 | $4.27 | |
| EPS (TTM) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | · | 710,700,000 | 716,500,000 | 716,300,000 | · | 723,000,000 | 737,600,000 | 740,600,000 | · | 739,400,000 | 737,300,000 | 729,400,000 | · | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | · | 713,700,000 | 719,100,000 | 720,800,000 | · | 729,400,000 | 742,400,000 | 748,600,000 | · | 745,900,000 | 744,700,000 | 737,200,000 | · | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.81 | $74.82 | · | $72.31 | $73.10 | $71.06 | · | $71.03 | $68.92 | $72.16 | · | $70.93 | $70.06 | $70.60 | · | $64.55 | |
| Revenue / Share | $8.85 | $8.37 | · | $8.48 | $8.25 | $7.96 | · | $7.95 | $7.74 | $7.74 | · | $9.21 | $9.61 | $9.72 | · | $10.39 | |
| Cash Flow / Share | · | $1.86 | · | · | · | $1.80 | · | · | · | $2.32 | · | · | · | $2.64 | · | · | |
| EPS (TTM) | $5.64 | $5.18 | · | $4.86 | $4.71 | $5.16 | · | $5.23 | $5.62 | $5.89 | · | $7.93 | $8.52 | $9.28 | · | $9.05 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $25.11B | $24.78B | · | $24.27B | $24.01B | $23.82B | · | $23.74B | $23.57B | $23.74B | · | $21.03B | $21.86B | $22.47B | · | $23.01B | |
| Net Income TTM | $4.00B | $3.69B | · | $3.50B | $3.41B | $3.77B | · | $3.89B | $4.20B | $4.40B | · | $5.92B | $6.36B | $6.93B | · | $6.76B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 34.8 | 35.0 | · | 38.0 | 42.2 | 39.9 | · | 52.7 | 44.5 | 42.4 | · | 27.7 | 25.0 | 24.1 | · | 25.3 | |
| P/S | 5.5 | 5.2 | · | 5.4 | 5.9 | 6.2 | · | 8.4 | 7.7 | 7.8 | · | 7.7 | 7.2 | 7.3 | · | 7.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| Dividend Yield | 0.70% | 0.71% | · | 0.65% | 0.57% | 0.53% | · | 0.39% | 0.43% | 0.43% | · | 0.51% | 0.53% | · | · | · | |
| Earnings Yield | 2.9% | 2.9% | · | 2.6% | 2.4% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 4.0% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · | |
| Annual Payout | · | $910M | · | $847M | $814M | $785M | · | $773M | $776M | $794M | · | $824M | $829M | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Brüt Kâr Marjı % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Faaliyet Kâr Marjı % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Net Gelir | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Seyreltilmiş Hisse Başı Kâr | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Cari Oran | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Cari Oran | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Kurumsal Sahipler (13F) 2.312 dosya · $121.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 148 (-60 önceki Ç'ye göre) | 182 (-73 önceki Ç'ye göre) | 694 (-87 önceki Ç'ye göre) | 1.024 (+88 önceki Ç'ye göre) | -368K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $13.959.166.172 | 60.978.360 | 11,53% | Hisse senetleri |
| BlackRock, Inc. | $10.492.520.322 | 55.084.630 | 8,66% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.881.505.437 | 41.377.076 | 6,51% | Hisse senetleri |
| FMR LLC | $5.626.949.757 | 29.540.895 | 4,65% | Hisse senetleri |
| STATE STREET CORP | $5.431.565.288 | 28.456.019 | 4,49% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $3.108.030.541 | 16.316.834 | 2,57% | Hisse senetleri |
| Capital International Investors | $2.953.960.497 | 15.504.420 | 2,44% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $2.707.246.740 | 14.280.335 | 2,24% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.705.808.973 | 14.205.213 | 2,23% | Hisse senetleri |
| JPMORGAN CHASE & CO | $2.349.101.825 | 12.185.400 | 1,94% | Hisse senetleri |
| MORGAN STANLEY | $2.161.750.127 | 11.348.958 | 1,79% | Hisse senetleri |
| Capital Research Global Investors | $2.060.650.455 | 10.818.030 | 1,70% | Hisse senetleri |
| NORGES BANK | $1.816.780.335 | 9.537.906 | 1,50% | Hisse senetleri |
| EAGLE CAPITAL MANAGEMENT LLC | $1.783.176.557 | 9.361.490 | 1,47% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.319.158.000 | 6.925.441 | 1,09% | Hisse senetleri |
| GENERATION INVESTMENT MANAGEMENT LLP | $1.287.948.806 | 6.761.596 | 1,06% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $1.222.064.214 | 6.489.965 | 1,01% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $1.021.898.650 | 5.364.861 | 0,84% | Hisse senetleri |
| Nuveen, LLC | $998.625.469 | 5.242.679 | 0,82% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $993.845.921 | 5.217.586 | 0,82% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $990.823.246 | 5.225.861 | 0,82% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983.459.478 | 5.163.059 | 0,81% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $979.232.536 | 5.140.868 | 0,81% | Hisse senetleri |
| Fisher Asset Management, LLC | $854.260.080 | 4.484.774 | 0,71% | Hisse senetleri |
| Legal & General Group Plc | $801.056.220 | 4.205.461 | 0,66% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $762.216.330 | 3.878.641 | 0,63% | Hisse senetleri |
| Invesco Ltd. | $753.537.418 | 3.955.992 | 0,62% | Hisse senetleri |
| FLOSSBACH VON STORCH SE | $747.259.707 | 3.923.035 | 0,62% | Hisse senetleri |
| Bank of New York Mellon Corp | $712.874.853 | 3.742.518 | 0,59% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $702.374.137 | 3.687.390 | 0,58% | Hisse senetleri |
| PARNASSUS INVESTMENTS, LLC | $699.862.950 | 3.674.207 | 0,58% | Hisse senetleri |
| Holocene Advisors, LP | $684.356.163 | 3.592.798 | 0,57% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $674.795.972 | 3.542.608 | 0,56% | Hisse senetleri |
| UBS Group AG | $617.826.451 | 3.243.524 | 0,51% | Hisse senetleri |
| Amundi | $549.255.875 | 2.883.536 | 0,45% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $507.487.046 | 2.664.239 | 0,42% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $505.131.601 | 2.651.651 | 0,42% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $503.199.762 | 2.641.746 | 0,42% | Hisse senetleri |
| BROWN ADVISORY INC | $500.677.350 | 2.628.487 | 0,41% | Hisse senetleri |
| ROYAL BANK OF CANADA | $455.982.000 | 2.393.859 | 0,38% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $446.265.498 | 2.342.847 | 0,37% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $444.130.104 | 2.331.466 | 0,37% | Hisse senetleri |
| FIL Ltd | $442.569.613 | 2.323.444 | 0,37% | Hisse senetleri |
| D1 Capital Partners L.P. | $434.682.789 | 2.282.039 | 0,36% | Hisse senetleri |
| FIRST MANHATTAN CO. LLC. | $429.106.102 | 2.248.424 | 0,35% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410.455.346 | 2.154.842 | 0,34% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $407.739.012 | 2.140.587 | 0,34% | Hisse senetleri |
| Castle Hook Partners LP | $404.836.478 | 2.125.349 | 0,33% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $402.413.634 | 2.029.727 | 0,33% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $401.433.291 | 2.107.482 | 0,33% | Hisse senetleri |
Aktivistler ve %5+ sahipler 9 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 başvurular | 02 Kasım 2021 | · | İlk başvuru | · | SEC |
| Steven M. Rales ×6 başvurular | 14 Haziran 2021 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 22 Ekim 2014 | · | İlk başvuru | M&A / satış | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 başvurular | 09 Aralık 2010 | · | İlk başvuru | · | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 başvurular | 05 Şubat 2010 | · | İlk başvuru | · | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 başvurular | 30 Mart 2007 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 23 Nisan 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 08 Haziran 2001 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 25 Mayıs 2001 | · | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 50 içeriden öğrenenler · 24 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | 21 Ağustos 2026 S | 0 | 0 | 3 | $-12.736.069 |
| Thomas Patrick Joyce JR | President and CEO | 24 Temmuz 2020 M | 203.513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | 18 Temmuz 2014 M | 512.199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | 15 Mayıs 2026 F | 8.291 | 0 | 2 | $-1.088.686 |
| Matthew Mcgrew | Executive Vice President | 01 Mart 2026 A | 26.825 | 0 | 1 | $-3.470.835 |
| Bradley R Gray | SVP Strategic Development | 01 Mart 2026 A | 14.463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | 04 Şubat 2026 A | 14.994 | 0 | 2 | $-4.773.810 |
| Daniel Raskas | SVP - Corporate Development | 01 Şubat 2025 A | 10.524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | 15 Mayıs 2024 M | 48.190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | 15 Mayıs 2024 F | 87.333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | 15 Mayıs 2023 F | 26.165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | 24 Şubat 2022 A | 47.962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | 13 Ağustos 2021 M | 16.155 | 0 | 0 | $0 |
| William K Daniel | EVP | 20 Şubat 2020 A | 109.886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | 10 Mayıs 2016 A | 113.198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | 28 Temmuz 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | 19 Mayıs 2015 M | 34.606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | 21 Şubat 2015 F | 174.406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | 29 Ocak 2010 A | 5.010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | 26 Ekim 2007 A | 4.400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | 01 Şubat 2007 M | 75.813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | 04 Mayıs 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | 31 Ağustos 2004 A | · | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | 01 Ocak 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 1.359 | 0 | 0 | $0 |
| John T Schwieters | Yönetim kurulu üyesi | 15 Temmuz 2025 M | 19.815 | 0 | 0 | $0 |
| Jessica L Mega | Yönetim kurulu üyesi | 15 Mayıs 2025 A | 3.302 | 0 | 0 | $0 |
| Pardis C Sabeti | Yönetim kurulu üyesi | 25 Ekim 2024 A | 5.283 | 0 | 0 | $0 |
| Walter G Lohr | Yönetim kurulu üyesi | 15 Şubat 2024 M | 14.129 | 0 | 0 | $0 |
| Donald J Ehrlich | Yönetim kurulu üyesi | 10 Şubat 2020 M | 123.203 | 0 | 0 | $0 |
| Robert J Hugin | Yönetim kurulu üyesi | 15 Mayıs 2017 A | 3.576 | 0 | 0 | $0 |
| Mortimer M Caplin | Yönetim kurulu üyesi | 26 Nisan 2013 A | 83.213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Yönetim kurulu üyesi | 30 Kasım 2007 M | 368.240 | 0 | 0 | $0 |
| Matthew E Gugino | · | 04 Ağustos 2026 A | 11.401 | 0 | 0 | $0 |
| Gregory M Milosevich | · | 04 Ağustos 2026 A | 24.467 | 0 | 1 | $-274.573 |
| Montgomery Julie A Sawyer | · | 04 Ağustos 2026 A | 22.221 | 0 | 0 | $0 |
| Christopher Paul Riley | · | 04 Ağustos 2026 A | 61.472 | 0 | 0 | $0 |
| Christopher Bouda | · | 04 Ağustos 2026 A | 9.107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | · | 04 Ağustos 2026 A | 32.495 | 0 | 0 | $0 |
| Jonathan Leiken | · | 04 Ağustos 2026 A | 12.546 | 0 | 0 | $0 |
| Mitchell P. Rales | · | 04 Ağustos 2026 A | 553.228 | 0 | 9 | $-234.561.260 |
| Steven M Rales | · | 04 Ağustos 2026 A | 3.605.808 | 0 | 0 | $0 |
| Shane A Sanders | · | 31 Temmuz 2026 A | 5.914 | 0 | 0 | $0 |
| Raymond C Stevens | · | 31 Temmuz 2026 A | 13.728 | 0 | 0 | $0 |
| Teri List-Stoll | · | 31 Temmuz 2026 A | 21.470 | 0 | 1 | $-746.997 |
| Feroz Dewan | · | 31 Temmuz 2026 A | 4.686 | 0 | 0 | $0 |
| Elias A. Zerhouni | · | 31 Temmuz 2026 A | 45.303 | 0 | 0 | $0 |
| Linda P Hefner | · | 31 Temmuz 2026 A | 26.829 | 0 | 0 | $0 |
| Alan G Spoon | · | 31 Temmuz 2026 A | 124.774 | 0 | 1 | $-237.202 |
| Daniel L Comas | · | 23 Ekim 2020 M | 92.683 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 125 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| JXX · Janus Detroit Street Trust | 4,03% | 5.508 NS | 31 Temmuz 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 3,22% | 235.300 NS | 31 Temmuz 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,62% | 29.365 NS | 31 Temmuz 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,16% | 1.006 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 2,04% | 369.897 SH | 11 Eylül 2026 | Günlük |
| GRW · TCW ETF Trust | 1,92% | 6.380 NS | 31 Temmuz 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,80% | 302.986 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,79% | 1.914.802 SH | 19 Ağustos 2026 | Günlük |
| MEDI · Harbor ETF Trust | 1,73% | 3.647 NS | 31 Temmuz 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,71% | 70.316 SH | 02 Ekim 2026 | Günlük |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,67% | 5.923 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 1,60% | 331.014 SH | 11 Eylül 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 1,41% | 12.395 NS | 31 Temmuz 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,30% | 147.190 NS | 31 Temmuz 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1,15% | 4.154 NS | 31 Temmuz 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,13% | 2.932 NS | 31 Temmuz 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,10% | 6.377 NS | 31 Temmuz 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 1,07% | 1.437 NS | 31 Temmuz 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,05% | 137.544 SH | 02 Ekim 2026 | Günlük |
| BKDV · BNY Mellon ETF Trust II | 1,03% | 96.880 NS | 31 Temmuz 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,81% | 46.812 NS | 31 Temmuz 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,79% | 2.199 NS | 31 Temmuz 2026 | N-PORT |
| XT · iShares Trust | 0,72% | 138.670 SH | 11 Eylül 2026 | Günlük |
| FFLC · FIDELITY COVINGTON TRUST | 0,59% | 36.489 NS | 31 Temmuz 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,59% | 165.000 | 02 Ekim 2026 | Günlük |
| MGV · VANGUARD WORLD FUND | 0,57% | 400.375 SH | 19 Ağustos 2026 | Günlük |
| PFM · Invesco Exchange-Traded Fund Trust | 0,55% | 20.005 SH | 02 Ekim 2026 | Günlük |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,52% | 3.558.711 SH | 19 Ağustos 2026 | Günlük |
| USXF · iShares Trust | 0,51% | 37.795 SH | 11 Eylül 2026 | Günlük |
| IWX · iShares Trust | 0,47% | 91.310 SH | 11 Eylül 2026 | Günlük |
| VTV · VANGUARD INDEX FUNDS | 0,45% | 6.058.224 SH | 19 Ağustos 2026 | Günlük |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,44% | 4.091 NS | 31 Temmuz 2026 | N-PORT |
| EVUS · iShares Trust | 0,43% | 8.232 SH | 11 Eylül 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 23.256 NS | 31 Temmuz 2026 | N-PORT |
| IVE · iShares Trust | 0,42% | 1.046.214 SH | 11 Eylül 2026 | Günlük |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,41% | 145.011 SH | 19 Ağustos 2026 | Günlük |
| IUSV · iShares Trust | 0,40% | 551.533 SH | 11 Eylül 2026 | Günlük |
| ILCV · iShares Trust | 0,38% | 25.086 SH | 11 Eylül 2026 | Günlük |
| SUSL · iShares Trust | 0,37% | 22.482 SH | 11 Eylül 2026 | Günlük |
| CHRI · Global X Funds | 0,37% | 153 NS | 31 Temmuz 2026 | N-PORT |
| DSI · iShares Trust | 0,36% | 97.358 SH | 11 Eylül 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,35% | 16.095 SH | 02 Ekim 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,35% | 277.749 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,34% | 1.404.243 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,34% | 381.505 SH | 19 Ağustos 2026 | Günlük |
| SUSA · iShares Trust | 0,29% | 58.103 SH | 11 Eylül 2026 | Günlük |
| OEF · iShares Trust | 0,27% | 266.715 SH | 11 Eylül 2026 | Günlük |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,25% | 346.000 | 02 Ekim 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,25% | 11.236 SH | 19 Ağustos 2026 | Günlük |
| DFLV · Dimensional ETF Trust | 0,24% | 84.826 NS | 31 Temmuz 2026 | N-PORT |
| DGRO · iShares Trust | 0,24% | 521.760 SH | 11 Eylül 2026 | Günlük |
| USCL · iShares Trust | 0,24% | 33.717 SH | 11 Eylül 2026 | Günlük |
| TOPC · iShares Trust | 0,23% | 381 SH | 11 Eylül 2026 | Günlük |
| MGC · VANGUARD WORLD FUND | 0,23% | 127.343 SH | 19 Ağustos 2026 | Günlük |
| ACVF · ETF Opportunities Trust | 0,23% | 1.783 NS | 31 Temmuz 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,23% | 17.834 SH | 02 Ekim 2026 | Günlük |
| IWL · iShares Trust | 0,22% | 24.594 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,22% | 102.555 SH | 02 Ekim 2026 | Günlük |
| SIZE · iShares Trust | 0,22% | 4.614 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 0,22% | 7.252 SH | 11 Eylül 2026 | Günlük |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 953.685 SH | 02 Ekim 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,21% | 142.869 SH | 19 Ağustos 2026 | Günlük |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 4.805 NS | 31 Temmuz 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,20% | 110.315 SH | 02 Ekim 2026 | Günlük |
| PBP · Invesco Exchange-Traded Fund Trust | 0,20% | 3.722 SH | 02 Ekim 2026 | Günlük |
| ILCB · iShares Trust | 0,20% | 12.530 SH | 11 Eylül 2026 | Günlük |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 88.851 NS | 31 Temmuz 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,19% | 10.899 NS | 31 Temmuz 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 18.450 SH | 11 Eylül 2026 | Günlük |
| IVV · iShares Trust | 0,19% | 7.939.826 SH | 11 Eylül 2026 | Günlük |
| VOXP · Advisors Series Trust | 0,19% | 57 NS | 31 Temmuz 2026 | N-PORT |
| XCLR · Global X Funds | 0,19% | 35 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,19% | 31.952 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,19% | 489 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,19% | 31.674 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 0,19% | 47 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,19% | 16.363.510 SH | 19 Ağustos 2026 | Günlük |
| VV · VANGUARD INDEX FUNDS | 0,19% | 743.939 SH | 19 Ağustos 2026 | Günlük |
| TOV · EA Series Trust | 0,19% | 2.581 NS | 31 Temmuz 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,19% | 53.257 NS | 31 Temmuz 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,19% | 2.836 NS | 31 Temmuz 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,19% | 22.752 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,19% | 616 NS | 31 Temmuz 2026 | N-PORT |
| IWB · iShares Trust | 0,18% | 437.462 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,18% | 27.014 SH | 11 Eylül 2026 | Günlük |
| PEVC · Pacer Funds Trust | 0,18% | 22 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,18% | 189.347 NS | 31 Temmuz 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,18% | 2.377 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,17% | 174.302 SH | 11 Eylül 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,17% | 15.178 NS | 31 Temmuz 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,17% | 5.511.000 | 02 Ekim 2026 | Günlük |
| ITOT · iShares Trust | 0,17% | 820.097 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,17% | 20.226.391 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,17% | 104.620 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,17% | 53.219 SH | 19 Ağustos 2026 | Günlük |
| ESGU · iShares Trust | 0,17% | 151.590 SH | 11 Eylül 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,17% | 493 SH | 02 Ekim 2026 | Günlük |
| TILT · FlexShares Trust | 0,16% | 18.486 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 0,15% | 1.797 SH | 11 Eylül 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,15% | 4.381 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,15% | 17.583 NS | 31 Temmuz 2026 | N-PORT |
| CRBN · iShares Trust | 0,15% | 8.649 SH | 11 Eylül 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,14% | 31.801 SH | 02 Ekim 2026 | Günlük |
| SPXL · Direxion Shares ETF Trust | 0,14% | 49.245 NS | 31 Temmuz 2026 | N-PORT |
| URTH · iShares, Inc. | 0,14% | 56.946 SH | 11 Eylül 2026 | Günlük |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,13% | 61.038 SH | 02 Ekim 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,13% | 83.138 NS | 31 Temmuz 2026 | N-PORT |
| ACWI · iShares Trust | 0,12% | 201.808 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,12% | 20.495 NS | 31 Temmuz 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3.770 SH | 02 Ekim 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,10% | 523.769 SH | 19 Ağustos 2026 | Günlük |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 7.398 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,08% | 206.412 NS | 31 Temmuz 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0,07% | 25.158 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 1.457 NS | 31 Temmuz 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,05% | 104.339 SH | 11 Eylül 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
DHR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
22 analist · 2026-10-02Ortalama hedef $234.73 +6,1%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.